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Objectives: Aflatoxins as a highly toxic group of mycotoxins are present in the
environment and foodstuff. These have been reported to cause serious health
problems in humans. Since aflatoxin M1 (AFM1) is excreted into breast milk,
investigating the exposure of infants to AFM1 is of special concern.
Methods: In the present study, breast milk samples were collected from 85
lactating mothers in Ilam province, Iran, and the levels of AFM1 were analyzed
using the enzyme-linked immunosorbent assay-based technique. AFM1 was
detected in breast milk of all lactating women. The mean contamination level
was 5.91  2.031 ng/L, ranging from 2 ng/L to 10 ng/L.
Results: Multiple regression analysis indicated no significant associations of
consumption of milk and dairy products, meat, fish, legumes, grain products,
fruits, and nuts with the concentration of AFM1 in breast milk. Furthermore, no
significant association was observed between AFM1 concentration and anthro-
pometric data of infants.
Conclusion: In western parts of Iran, lactatingmothers and their infants could be at
risk of aflatoxin B1 and AFM1 exposure, respectively. Therefore, in Iran, the evalu-
ation of AFM1 in human breast milk as a biomarker for postnatal exposure of infants
to this carcinogen requires more attention in different regions and various seasons.1. Introduction
Aflatoxins are a highly toxic group of mycotoxins that
are produced by certain species of the genus Aspergillus,
especiallyAspergillus flavus,Aspergillus parasiticus, andiyari-s@medilam.ac.ir (S. Ba
uted under the terms of th
.org/licenses/by-nc-nd/4.0
ginal author and source are
ase Control and PreventionAspergillus nomius [1]. These fungal metabolites are
primarily found in different plant and plant products,
especially nuts and grains [2]. Several experimental
studies have shown that aflatoxins are highly toxic to the
liver, and may cause hepatic cancer and acute liverkhtiyari).
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nosuppressive, mutagenic, and teratogenic [5]. More than
18 aflatoxins have been identified, among which aflatoxin
B1 (AFB1) is the most potent carcinogen. In animals fed
with AFB1-contaminated food, this toxin is converted
into a secondary hydroxylatedmetabolite named aflatoxin
M1 (AFM1), which is subsequently secreted in milk and
excreted in urine and feces [6,7]. In fact, AFM1 is
detectable in mother’s milk at 12e24 hours after the
consumption of contaminated food. It rapidly decreases
with time and is not detectable after 3 days of stopping the
intake of contaminated foodstuff [8]. The transplacental
transfer of AFM1 through the fetoplacental interface has
been established.Milk and its products are one of themain
staples of humans. However, consumption of contami-
nated milk and dairy products has been shown to cause
serious health problems, and children as the major con-
sumers of milk are at high risk for the life-threatening side
effects of aflatoxins [6e8]. Recently, the International
Agency for Research on Cancer has reconsidered AFM1
as a Group 1 carcinogen. Since AFM1 is resistant to high
temperatures used in autoclaving and pasteurization
processes [9], there is an urgent need for developing
strategies to reduce the aflatoxin levels during the pro-
duction of milk and milk products, especially during the
storage phases. Many countries have regulations to con-
trol the levels of AFM1 in milk and milk products. The
European Commission recommends that the maximum
level of AFM1 in raw milk and dairy products should not
exceed 50 ng/kg [10], and for infant food it is limited to
25 ng/kg. However, in China, the maximum permissible
level of AFM1 is 500 mg/kg. In Austria and Switzerland,
this limit is even lower at 10 ng/kg for baby food [11].
As AFM1 is secreted in human breast milk, infants
and neonates are potentially exposed to the adverse ef-
fects of aflatoxins such as growth impairment, under-
weight, and infectious diseases [12,13]. Therefore,
investigating the presence and level of AFM1 in human
breast milk is of special concern. Several studies have
been conducted in different countries to explore the
AFM1 levels in breast milk of lactating mothers, and
various results have been obtained. Data regarding the
AFM1 levels in human breast milk in Iran are insuffi-
cient, and to our knowledge, no study has been con-
ducted in Ilam province. Therefore, the purpose of the
present study was to evaluate the presence and level of
AFM1 in lactating mothers in Ilam, and investigate the
possible correlations between AFM1 levels and anthro-
pometric parameters of infants.2. Material and methods
2.1. Participants and protocol
A total of 85 samples were collected from lactating
mothers in Ilam province, west of Iran, during
AprileOctober 2014. All volunteers who agreed toparticipate in this study had full-term delivery. The
research protocol was approved by the Ethics Commit-
tee of Deputy of Research, Ilam University of Medical
Sciences, Ilam, Iran. The participants were informed
about the study protocol, and if they agreed to
contribute, a written informed-consent agreement was
signed. The inclusion criterion was that the lactating
women should be apparently healthy. The exclusion
criteria were chronic diseases (e.g., diabetes mellitus
and cancer), infections, use of medication, and smoking.
At the time of sampling, a questionnaire was filled in
giving details of age, gestational age, stage of lactation,
postnatal age, sex, birth weight, weight at the time of
sampling, and mother’s diet (including frequency of
consumption of milk and milk products, pistachios, nuts,
rice, fruits, vegetables, and meat within 72 hours before
milk sampling). Complementary data regarding the so-
cioeconomic position of the mothers, namely, their in-
come, job, and education level, were gathered.
2.2. Sample preparation
Ten milliliters of breast-milk samples were collected
by hand expression or manual breast pump during regular
feeding of infants into sterile plastic containers. The
samples were transported to the laboratory in refrigerated
containers (4C) and stored at 20C until use. Five
milliliters of each milk sample were incubated for 30
minutes at 4C and centrifuged at 16,100 g for 5 minutes.
The skimmed milk below the fat layer was sampled,
transferred to a new test tube, and stored at 
20C until use. A competitive enzyme-linked immuno-
sorbent assay (ELISA)-based kit (Beacon Analytical
Systems Inc., Portland, ME, USA) was used to determine
the AFM1 levels in the skimmed milk sample obtained.
2.3. Analysis of AFM1 in samples by
competitive ELISA
The obtained skimmed milk samples and kit contents
were left outside for 30 minutes to reach the room
temperature. The AFM1 levels were determined ac-
cording to the manufacturer’s instructions. Briefly,
100 mL of the standards and milk sera were transferred
to a microtiter plate precoated with AFM1 antibody
(supplied with the kit). All samples and standards were
assayed in duplicate. The plate was gently shaken and
incubated at room temperature for 30 minutes. After the
incubation time, the AFM1 horseradish peroxidase
(HRP)-conjugated antibody was added to the plate and
incubated at room temperature for further 15 minutes.
The plate was then washed four times with the washing
solution in order to remove the unbound conjugated
antibody. The substrate solution (100 mL) was added
into the wells, and the reaction was allowed to proceed
in the dark for 30 minutes at room temperature resulting
in the formation of a blue color. The reaction was then
stopped by adding 100 mL of stop solution, which
changed the color to yellow. Finally, the absorbance was
Table 1. Descriptive data of the study.
Variables N Range Mean  SD
Mother age (y) 85 19e40 26.31  5.12
Mother weight (kg) 85 46e71 57.94  10.38
Mother height (cm) 85 140 158.1  12.55
Mother BMI 85 18e28 24.61  3.44
Infant age (mo) 85 0.2e21 7.68  2.21
Infant height at birth (cm) 85 41e67 60.21  5.12
Infant weight at birth (kg) 85 1.97e4.1 3.18  0.75
Infant weight at the time of sampling 85 3.11e8.16 5.90  1.12
Infant head circumference (cm) 85 32e44 39  2.01
BMI Z body mass index; N Z number; SD Z standard deviation.
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Durham, NC, USA). A standard curve was drawn by
plotting absorbance values against AFM1 concentra-
tions. The absorption intensity was inversely propor-
tional to AFM1 concentration in milk samples.
2.4. Statistical analysis
Statistical analysis was performed using SPSS
version 16 software. The data were analyzed using
multiple linear regressions to evaluate the association
between AFM1 concentrations in breast milk and the
potential factors as well as infants’ anthropometric sta-
tus. A p value of < 0.05 was considered statistically
significant [14].3. Results
Descriptive data of 85 mothers and their infants are
presented in Table 1. AFM1 was detected in breast milk
of all lactating women. The mean contamination level
was 5.91  2.031 ng/L, ranging between 2 ng/L and
10 ng/L (Table 2).
Multiple regression analysis indicated no significant
associations of consumption of milk and dairy products,
meat, fish, legumes, grain products, fruits, and nuts with
the concentration of AFM1 in breast milk. In addition,
no significant association was observed between AFM1
concentration and anthropometric data of infants.4. Discussion
Infancy is regarded as a unique period in human life,
mainly due to the dependence of infants on mother’s breastTable 2. Occurrence of AFM1 in human breast milk.
Sample N Positive samples
Human breast milk 85 85 (100)
AFM1 Z aflatoxin M1; N Z number; SD Z standard deviation.milk as the only nutritional source [15]. Human breast milk
is the most bioavailable source of nutrients for infants,
which also provides the hormones and immunological
factors that protect the infants from potential disease-
causing agents [16]. Several factors have been reported to
affect the quality of human breast milk, among which
maternal consumption of contaminated food is considered
to be the main cause of breast milk contamination. Afla-
toxins as a highly carcinogenic, mutagenic, and teratogenic
group of mycotoxins [17] are regarded as one of the most
naturally occurring toxins threatening the human health.
Since the rate of biotransformation is lower in children
compared to that in adults and due to a higher growth rate
along with more consumption of food and water/kg weight
[18], children are considered to be highly susceptible to the
detrimental effects of environmental toxins, specially afla-
toxins. Early infant exposure to aflatoxins has shown to
result in immunosuppression, growth impairment, and un-
derweight. Several studies have reported the presence of
AFM1 in infant formula as well as in human breast milk in
different countries. Therefore, AFM1 in breast milk of
lactating mothers can be considered as a potential health-
threatening issue for infants.
In the present study, the concentration of AFM1 in
the breast milk of 85 lactating women of Ilam province
was measured. AFM1 was found in all samples with a
mean contamination level of 5.91  2.031 ng/L, ranging
from 2 ng/L to 10 ng/L.
Data regarding the frequency and mean concentration
of AFM1 in breast milk samples vary in different
countries, indicating that the contamination rate is lower
in the developed countries compared to that in devel-
oping/undeveloped countries. Studies from Germany,
France, and England reported no contamination in breast
milk samples [19,20]. However, the results of a study in(%)
AFM1 contamination (ng/L)
Range Mean  SD
2e10 5.91  2.031
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lactating women were contaminated with AFM1, which
can be attributed to the warm and humid climate of this
country [21].
The presence of AFM1 in breast milk samples of
lactating women in different provinces of Iran has been
evaluated, and various results have been obtained. The
frequency of contamination of samples in our study
(100%) was similar to that previously reported for Tehran
province of Iran (98%) [22]. However, in that study, the
mean concentration of AFM1 was 8.2  5.1 ng/L. Mah-
davi et al [23] have also recently evaluated the presence of
AFM1 in breast milk of lactating mothers in urban and
rural areas in Tabriz (Iran). In their study, the frequency of
contamination in rural areas was 22%, while there was no
AFM1-positive sample in urban areas. In a recent study in
Isfahan (Iran), AFM1 was found in only one out of 80
breast milk samples (1.25%), with a mean concentration
of 6.88 ng/L.
Themean concentration ofAFM1 in our study (5.91 ng/
L)was lower than the reportedvalues forAustralia (560ng/
L) [24], United Arab Emirates (664 ng/L) [25], Egypt
(13.5 ng/L) [26], Tehran (8.2 5.1 ng/L) [22], and Sudan
(400 ng/L) [27].
Since diet is regarded as the main source of human
exposure to aflatoxins, consumption of AFB1-
contaminated food might result in the secretion and pres-
ence of AFM1 in breast milk. Polychronaki et al [26] have
found a relationship between the occurrence of AFM1 in
breast milk of lactating women, and consumption of
groundnuts and corn.Other studies in different countries as
well as in different parts of Iran have also related con-
sumption of milk and dairy products, peanuts, pistachios,
nuts, corn, and certain food products with the presence and
level of AFM1 in breast milk samples [22,24,28]. How-
ever, in the present study, multiple linear regression anal-
ysis failed to show any significant correlation of AFM1
concentrationwith infant anthropometric parameters or the
type and amount of food consumed.
According to the European Commission and US
regulation, the maximum level of AFM1 for infant food
commodities should not exceed 25 ng/kg. However,
Austria and Switzerland have fixed the limit to 10 ng/kg
for infant milk. In the present study, the mean concen-
tration of AFM1 in human breast milk (5.91  2.031 ng/
L) was lower than the maximum tolerable limit accepted
by the European Union and US regulation (p < 0.01). It
was also lower than the maximum limit accepted by
Austria and Switzerland (p < 0.01).
In conclusion, an analysis of the breast milk of Iranian
women indicated exposure of mothers to aflatoxins
through their normal diet. Based on our results, the
calculated average infant exposure to AFM1 showed that
infants are exposed to an average of 2e5.6 mg/kg AFM1
daily from breastfeeding in Ilam, Iran, which is still lower
than the accepted limit [29]. However, due to the low
biotransformation rate of infants, attempts should bedirected toward finding ways to reduce the contamination
of foods with aflatoxins. Therefore, in order to reduce the
presence of aflatoxins in breast milk and infant exposure,
people, especially mothers, should be educated about the
ways of conveyance of aflatoxin into foods, and associ-
ated hazards following unsuitable food storage and
ingestion of contaminated foods. Finally, this warrants the
need for monitoring the AFM1 level in human breast milk
samples over the breastfeeding period.Conflicts of interest
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